29.70
前日終値:
$27.50
開ける:
$27.82
24時間の取引高:
5.03M
Relative Volume:
1.21
時価総額:
$8.39B
収益:
$907.29M
当期純損益:
$33.98M
株価収益率:
-20.27
EPS:
-1.4655
ネットキャッシュフロー:
$115.75M
1週間 パフォーマンス:
-2.27%
1か月 パフォーマンス:
+22.02%
6か月 パフォーマンス:
+64.54%
1年 パフォーマンス:
-2.56%
Caris Life Sciences Inc Stock (CAI) Company Profile
名前
Caris Life Sciences Inc
セクター
電話
(866) 771-8946
住所
750 W JOHN CARPENTER FREEWAY, IRVING
Compare CAI vs VRTX, MRNA, REGN, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CAI
Caris Life Sciences Inc
|
29.70 | 8.39B | 907.29M | 33.98M | 115.75M | -1.4655 |
|
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 129.29B | 12.34B | 4.34B | 3.71B | 16.87 |
|
MRNA
Moderna Inc
|
225.00 | 89.83B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 76.86B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
825.03 | 51.88B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
189.76 | 40.67B | 742.00K | -1.37B | -1.07B | -7.0731 |
Caris Life Sciences Inc Stock (CAI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-09-09 | 開始されました | UBS | Neutral |
| 2026-06-02 | 再開されました | Wolfe Research | Peer Perform |
| 2026-04-13 | 開始されました | Jefferies | Buy |
| 2026-04-10 | 開始されました | Piper Sandler | Neutral |
| 2026-04-01 | 開始されました | Goldman | Buy |
| 2026-02-17 | 開始されました | Robert W. Baird | Outperform |
| 2025-12-02 | 開始されました | Canaccord Genuity | Hold |
| 2025-07-14 | 開始されました | BTIG Research | Buy |
| 2025-07-14 | 開始されました | BofA Securities | Buy |
| 2025-07-14 | 開始されました | Citigroup | Buy |
| 2025-07-14 | 開始されました | Evercore ISI | Outperform |
| 2025-07-14 | 開始されました | Guggenheim | Buy |
| 2025-07-14 | 開始されました | JP Morgan | Overweight |
| 2025-07-14 | 開始されました | TD Cowen | Buy |
| 2025-07-14 | 開始されました | Wolfe Research | Outperform |
| 2021-06-30 | ダウングレード | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-06-21 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-06-09 | 再開されました | B. Riley Securities | Buy |
| 2020-12-09 | 開始されました | B. Riley Securities | Buy |
| 2020-10-19 | アップグレード | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-06-15 | ダウングレード | Keefe Bruyette | Outperform → Mkt Perform |
| 2020-05-07 | アップグレード | Keefe Bruyette | Mkt Perform → Outperform |
| 2019-11-05 | ダウングレード | Cowen | Outperform → Market Perform |
| 2019-08-08 | 繰り返されました | Cowen | Outperform |
| 2019-02-21 | ダウングレード | Keefe Bruyette | Outperform → Mkt Perform |
| 2018-10-31 | 繰り返されました | Cowen | Outperform |
| 2018-09-28 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2018-09-07 | アップグレード | Keefe Bruyette | Mkt Perform → Outperform |
| 2018-04-24 | 開始されました | Compass Point | Buy |
| 2018-02-15 | 繰り返されました | Cowen | Outperform |
| 2018-02-14 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2017-10-23 | アップグレード | Cowen | Market Perform → Outperform |
| 2017-07-27 | 繰り返されました | Cowen | Market Perform |
| 2017-04-21 | 繰り返されました | Cowen | Market Perform |
| 2016-05-04 | 繰り返されました | Cowen | Market Perform |
| 2016-02-17 | 繰り返されました | Cowen | Market Perform |
| 2016-01-15 | 再開されました | Keefe Bruyette | Mkt Perform |
すべてを表示
Caris Life Sciences Inc (CAI) 最新ニュース
Caris Life Sciences (NasdaqGS:CAI) Stock Forecast & Analyst Predictions - Simply Wall Street
Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com Canada
Caris Life Sciences SVP Denton sells $238,626 in shares - Investing.com
Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com South Africa
Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com India
Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com UK
Insider at Caris Life Sciences (CAI) lines up stock sale - Stock Titan
Caris Life Sciences(CAI.US) Officer Sells US$12.13 Million in Common Stock - Moomoo
Caris Life Sciences vice chairman Brille sells $12.1 million shares By Investing.com - Investing.com UK
Caris Life Sciences (CAI) director plans 400,000-share sale - Stock Titan
Caris Life Sciences vice chairman Brille sells $12.1 million shares - Investing.com
New investor pitch from Caris Life Sciences (CAI) set for Morgan Stanley healthcare event - Stock Titan
UBS Group Upgrades Caris Life Sciences (NASDAQ:CAI) to "Hold" - MarketBeat
Amundi Buys 1,197,392 Shares of Caris Life Sciences, Inc. $CAI - MarketBeat
Squarepoint Ops LLC Acquires Shares of 380,927 Caris Life Sciences, Inc. $CAI - MarketBeat
Menlo Advisors LLC Acquires Shares of 300,518 Caris Life Sciences, Inc. $CAI - MarketBeat
UBS Initiates Coverage on Caris Life Sciences With Neutral Rating, $28 Price Target - marketscreener.com
Caris Life Sciences launches national campaign with Kevin Costner to promote early cancer detection test Caris Detect. - Pluang
Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect - PR Newswire
Could Caris Life Sciences (CAI) Be 7% Undervalued After Its Lung Cancer Research Update? - Yahoo Finance
47,595 Shares in Caris Life Sciences, Inc. $CAI Acquired by The Manufacturers Life Insurance Company - MarketBeat
Caris Life Sciences (CAI) Will Present Seven Studies At A Global Lung Conference - Yahoo Finance
Bank of New York Mellon Corp Takes Position in Caris Life Sciences, Inc. $CAI - MarketBeat
David Baxley Spetzler Sells 478,000 Shares of Caris Life Sciences (NASDAQ:CAI) Stock - MarketBeat
Insider Selling: Caris Life Sciences (NASDAQ:CAI) President Sells 119,212 Shares of Stock - MarketBeat
President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com Nigeria
President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com South Africa
President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com Australia
President Spetzler sells $14.8m in Caris Life Sciences stock - Investing.com India
President Spetzler sells $14.8m in Caris Life Sciences stock - investing.com
President Spetzler sells $14.8m in Caris Life Sciences stock - Investing.com
After an $11.9M stock sale, Caris Life Sciences (NYSE: CAI) holder plans another - Stock Titan
President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com Canada
Insider at Caris Life Sciences (CAI) lines up 2026 stock sale tied to expiring options - Stock Titan
Braidwell LP Purchases 246,585 Shares of Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer - Morningstar
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer - PR Newswire
Moore Capital Management LP Makes New Investment in Caris Life Sciences, Inc. $CAI - MarketBeat
Deutsche Bank AG Purchases New Position in Caris Life Sciences, Inc. $CAI - MarketBeat
BlackRock Inc. Acquires New Stake in Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Canada Pension Plan Investment Board Purchases Shares of 1,374,952 Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer - sahmcapital.com
Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer - PR Newswire
PointState Capital LP Makes New Investment in Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences (NASDAQ:CAI) Trading Down 6.2%What's Next? - marketbeat.com
Bank of America Corp DE Lowers Stake in Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences Stock Is Up 65% in Three Months, But Its Valuation Multiple Just Got Cheaper. - TIKR.com
Caris Life Sciences (NASDAQ: CAI) trust plans another stock sale - Stock Titan
Mitsubishi UFJ Asset Management Co. Ltd. Invests $1.52 Million in Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences Inc (CAI) 財務データ
収益
当期純利益
現金流量
EPS
Caris Life Sciences Inc (CAI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| JOHN RUSSEL DENTON | Officer |
Sep 22 '26 |
Proposed Sale |
31.82 |
7,500 |
238,626 |
0 |
| Brille Brian J | See Remarks |
Sep 17 '26 |
Sale |
30.33 |
400,000 |
12,132,080 |
230,303 |
| BRIAN J BRILLE | Officer |
Sep 17 '26 |
Proposed Sale |
30.33 |
400,000 |
12,132,080 |
0 |
| Brille Brian J | See Remarks |
Sep 17 '26 |
Option Exercise |
2.44 |
400,000 |
976,000 |
630,303 |
| DAVID SPETZLER | Officer |
Sep 04 '26 |
Proposed Sale |
24.76 |
119,212 |
2,951,117 |
0 |
| Spetzler David Baxley | President |
Sep 04 '26 |
Option Exercise |
2.44 |
250,000 |
610,000 |
1,302,083 |
| Spetzler David Baxley | President |
Sep 04 '26 |
Sale |
24.76 |
119,212 |
2,951,117 |
1,182,871 |
| Spetzler David Baxley | President |
Sep 03 '26 |
Option Exercise |
2.44 |
1,000,000 |
2,440,000 |
1,530,083 |
| DAVID SPETZLER | Officer |
Sep 03 '26 |
Proposed Sale |
24.86 |
478,000 |
11,882,984 |
0 |
| Spetzler David Baxley | President |
Sep 03 '26 |
Sale |
24.86 |
478,000 |
11,882,990 |
1,052,083 |
大文字化:
|
ボリューム (24 時間):